Skip to main content
Clinical Trials/NCT01529996
NCT01529996CompletedNot Applicable

Comparison of the Efficacy Between Pulsed Dye Laser (PDL) and the Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness: A Pilot, Prospective Randomized Trial.

Northwestern University1 site in 1 country16 target enrollmentStarted: January 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
16
Locations
1
Primary Endpoint
Rating on global improvement scale

Study Overview

Brief Summary

The primary objective of this study is to compare the efficacy of PDL and the 1064-nm Nd:YAG laser in the treatment of facial redness.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy patients 18-55 years of age with erythematotelangiectatic rosacea (as verified by the the PI).
  • •Subjects who are willing to provide informed consent for participation in the study.

Exclusion Criteria

  • •Pregnant or lactating individuals
  • •Subjects who are unable to understand the protocol or to give informed consent.
  • •Subjects who have a known history of photosensitive conditions (e.g. Systemic lupus, polymorphous light eruption)
  • •Subjects who have facial telangiectasia of diameter greater than 2 mm.
  • •Subject who have significant (as determined by the PI) acute inflammatory papules, pustules, and vesicle involving the central face.

Arms & Interventions

YAG laser

Experimental

Intervention: Pulse Dye Laser/YAG laser (Procedure)

Pulse Dye Laer

Active Comparator

Intervention: Pulse Dye Laser/YAG laser (Procedure)

Outcomes

Primary Outcomes

Rating on global improvement scale

Time Frame: four months

Non-treating dermatologists will rate each side of the face using a global improvement scale to evaluate the effectiveness of the two treatments.

Spectrophotometer measurement

Time Frame: four months

Spectrophotometer measurement as the percent resolution on each follow up visit compared to baseline visit

Secondary Outcomes

  • Recorded discomfort(four months)
  • Patient satisfaction(four months)
  • Adverse events(four months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Murad Alam

Professor in Dermatology, Otolaryngology - Head and Neck Surgery, and Surgery-Organ Transplantation

Northwestern University

Study Sites (1)

Loading locations...

Similar Trials